Back to search

Article

Treatment of sarcoidosis with cutaneous involvement with tofacitinib

2021-07-05

Abstract excerpt

Sarcoidosis is an idiopathic inflammatory disorder that is commonly treated with glucocorticoids and there are no approved steroid-sparing medications. There is emerging evidence that Janus kinase (JAK) inhibitors, which inhibit JAK-dependent cytokine activity, may hold promise in sarcoidosis. In this open-label trial, 10 patients with recalcitrant sarcoidosis with cutaneous involvement were treated with tofacitin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d1f4c64c-bb2e-58d2-a916-1338f04cdc51
DOI
10.1101/2021.07.01.21259700
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treatment of sarcoidosis with cutaneous involvement with tofacitinibDOI 10.1101/2021.07.01.21259700
Select a neighboring publication to make it the new centre.